Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2014
05/06/2014US8715671 Compositions and methods for modulating immune response
05/06/2014US8715670 Human monoclonal antibody that specifically binds to VCAM-1 and a composition for treating an inflammatory disease or a cancer comprising the same
05/06/2014US8715669 Anti-IL-17A/IL-17F cross-reactive antibodies
05/06/2014US8715668 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor DR5 and uses thereof
05/06/2014US8715667 Methods of treating patients having TLR3-positive cancer
05/06/2014US8715666 Method for the potentiation of opioid analgesics effects on pain
05/06/2014US8715665 Methods for treating cancer resistant to ErbB therapeutics
05/06/2014US8715664 Use of human TNFα antibodies for treatment of erosive polyarthritis
05/06/2014US8715663 Epitopes
05/06/2014US8715662 Anti-trop-2 monoclonal antibodies and uses thereof in the treatment and diagnosis of tumors
05/06/2014US8715660 Treatment of angiogenesis disorders
05/06/2014US8715659 Single domain brain-targeting antibody fragments derived from llama antibodies
05/06/2014US8715658 Methods for treating conditions mediated by the inflammatory cytokine cascade using GAPDH inhibitors
05/06/2014US8715657 Therapeutic antibodies binding IL12Rβ1
05/06/2014US8715656 Therapeutic use of specific ligand in MSRV associated diseases
05/06/2014US8715655 Human anti-α9 integrin antibody
05/06/2014US8715654 Methods of modulating the negative chemotaxis of immune cells
05/06/2014US8715653 Modulation of Rhamm (CD168) for selective adipose tissue development
05/06/2014US8715652 Immunoglobulin preparations having increased stability
05/06/2014US8715649 Compositions and methods of use for alpha-1 antitrypsin having no significant serine protease inhibitor activity
05/06/2014US8715638 Ethenyl-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
05/06/2014US8715620 Treatment of asthma in mammals with clostridia neurotoxins
05/06/2014US8715619 Compositions and methods for treating haematological proliferative disorders of myeloid origin
05/06/2014CA2798924C Improved methods for preparing squalene
05/06/2014CA2711798C Composition comprising antibody that binds to domain ii of her2 and acidic variants thereof
05/06/2014CA2700812C Immune stimulatory oligonucleotide analogs containing modified sugar moieties
05/06/2014CA2687583C Chimeric and humanized anti-cd44 antibodies that mediate cancer cell cytotoxicity
05/06/2014CA2682212C Anti-sclerostin antibodies
05/06/2014CA2637690C Tumour vaccine comprising allogeneic or xenogeneic tumour cells
05/06/2014CA2631292C Derivatised wt1 cancer antigen peptides and their use
05/06/2014CA2616210C Influenza vaccine compositions
05/06/2014CA2612937C Concentrated protein lyophilates, methods, and uses
05/06/2014CA2585638C Aminopyridine derivatives having aurora a selective inhibitory action
05/06/2014CA2577692C Methods and compositions for treatment of hematologic cancers
05/06/2014CA2555210C Chemically programmable immunity
05/06/2014CA2534870C Polysaccharide-protein conjugate vaccines
05/06/2014CA2518262C Uses of il-23 agonists and antagonists; related reagents
05/06/2014CA2511838C Uses of mammalian cytokine; related reagents
05/06/2014CA2475446C Viral variants with altered susceptibility to nucleoside analogs and uses thereof
05/06/2014CA2401327C Nucleic acid formulations comprising poly-amino acids for gene delivery and methods of use
05/06/2014CA2287911C Apo-2 receptor
05/01/2014WO2014066860A2 Methods of prognosticating and treating cancer
05/01/2014WO2014066856A1 Inhalable influenza vaccine compositions and methods
05/01/2014WO2014066830A1 Composition and methods for the prevention and treatment of diet-induced obesity
05/01/2014WO2014066744A2 Anti-complement c1s antibodies and uses thereof
05/01/2014WO2014066677A1 Anti-infective binding proteins that bind aip2
05/01/2014WO2014066532A1 Combination of anti-kir and anti-ctla-4 antibodies to treat cancer
05/01/2014WO2014066487A2 Methods for treating anemia
05/01/2014WO2014066468A1 Stable, low viscosity antibody formulation
05/01/2014WO2014066341A1 Use of the salmonella spp type iii secretion proteins as a protective vaccination
05/01/2014WO2014066328A1 Methods of treating neuroendocrine tumors using wnt pathway-binding agents
05/01/2014WO2014066271A1 Non-b-lineage cells capable of producing antibody
05/01/2014WO2014066167A1 Antibodies to interleukin-6 and uses thereof
05/01/2014WO2014066058A1 Dual variable domain (dvd) immunoglobulins for reducing major adverse cardiovascular events (mace) in diabetic patients subsequent to stent placement
05/01/2014WO2014065679A1 Lyme disease vaccine
05/01/2014WO2014065606A1 Agent for treating nerve disease, comprising osmotin composition and inhibitor for inhibiting expression or activity of gaba b receptor proteins
05/01/2014WO2014065403A1 Anti-human cd40 monoclonal antibody, and use thereof
05/01/2014WO2014065402A1 Anti-human cd40 monoclonal antibody, and use thereof
05/01/2014WO2014065375A1 Method for inhibiting proliferation of cell by oxidative stress
05/01/2014WO2014065229A1 Adjuvant and vaccine including same
05/01/2014WO2014065210A1 Vaccine for preventing porcine edema disease
05/01/2014WO2014064943A1 Antigenic peptide derived from dengue virus
05/01/2014WO2014064707A1 Pichia pastoris -expressed dengue virus like particles
05/01/2014WO2014064682A1 Combinations of epidermal growth factor receptor targeting antibodies for treating cancer
05/01/2014WO2014064637A1 Stable pharmaceutical composition of tnfr:fc fusion protein
05/01/2014WO2014064488A1 Streptococcus thermophilus strains for treating helicobacter pylori infection
05/01/2014WO2014064292A1 A method for preventing or treating atrial fibrillation
05/01/2014WO2014064236A1 Cross-protecting salmonella vaccines
05/01/2014WO2014064229A1 Nicotinamide as adjuvant
05/01/2014WO2014064217A1 Immunogenic composition against aeromonas hydrophila
05/01/2014WO2014064192A1 Method and pharmaceutical composition for use in the treatment and prediction of myocardial infraction
05/01/2014WO2014063832A1 Pr13.5 promoter for robust t-cell and antibody responses
05/01/2014WO2014063703A1 Monoclonal antibodies
05/01/2014WO2014063601A1 Vaccine for inducing specific immunity of tumor and application thereof
05/01/2014WO2014063368A1 Humanized monoclonal antibody in extracellular domain of anti-human death receptor 5
05/01/2014WO2014063253A1 Anti-campylobacter jejuni antibodies and uses therefor
05/01/2014WO2014063205A1 Use of endocytosis inhibitors and antibodies for cancer therapy
05/01/2014WO2014037785A3 Catalytic antibodies and uses thereof
05/01/2014WO2014036314A3 Diagnosis of rheumatoid arthritis (ra) using differentially methylated loci identified in peripheral blood mononuclear cells, t-cells, b-cells and monocytes
05/01/2014WO2014031646A3 Molecules with antigen binding and polyvalent fc gamma receptor binding activity
05/01/2014WO2014028668A3 Stem cell enhancing therapeutics
05/01/2014WO2014008263A3 Paramyxovirus and methods of use
05/01/2014WO2014005153A3 Methods for treating mds1-evi1 mediated cancer
05/01/2014WO2013186793A9 Rice bran-lipids based formulation and process for preparation thereof for selective delivery of genes to cancer cells
05/01/2014WO2013176754A9 Novel purification of antibodies using hydrophobic interaction chromatography
05/01/2014WO2013168182A3 Vaccine combinations
05/01/2014WO2013088378A3 Method of detecting the presence of an antibody in a sample
05/01/2014WO2013025834A9 Compositions and methods related to antibodies to staphylococcal protein a
05/01/2014WO2013003037A3 Anti-erbb3 antibodies in combination with paclitaxel for treatment of gynecological cancers
05/01/2014WO2012138768A3 Anti-cd154 antibodies having impaired fcr binding and/or complement binding properties and the use thereof in immune therapies
05/01/2014WO2012135575A3 Compositions and methods for introduction of macromolecules into cells
05/01/2014US20140120614 Antibodies against clostridium difficile toxins and uses thereof
05/01/2014US20140120156 Compositions and methods for exosome targeted expression
05/01/2014US20140120139 Methods for inducing an immune response via buccal and/or sublingual administration of a vaccine
05/01/2014US20140120138 Pharmaceutical compositions comprising attenuated plasmodium sporozoites and glycolipid adjuvants
05/01/2014US20140120135 Aqueous composition comprising a biological antigen and an acrylic acid polymer
05/01/2014US20140120134 Live, oral vaccine for protection against shigella dysenteriae serotype 1
05/01/2014US20140120133 Vaccine Against African Horse Sickness Virus
05/01/2014US20140120132 Lentiviral vectors containing an mhc class i promoter
05/01/2014US20140120131 Composition comprising iscom particles and live micro-organisms
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 1823